URINALYSIS MARKET ANALYSIS

Regional Analysis

Global Urinalysis Market: Regional Insights

Based on region, the global urinalysis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period due to the increasing prevalence of chronic kidney disease, Urinary Tract Infections (UTIs), diabetes, growing geriatric population, and increasing awareness among people in the region. For instance, chronic kidney diseases can be diagnosed with blood and urine tests, such as urinalysis. According to the US Centers for Disease Control and Prevention (CDC), 1 in 7 people in the U.S., about 35.5 million adults, are estimated to have CKD in 2023. Moreover, 9 in 10 adults with CKD do not know they have it and 1 in 3 adults with severe CKD do not know they have CKD.

Europe and Asia Pacific are also expected to witness robust growth in the global urinalysis market due to the rise in burden of chronic disease, such as chronic kidney diseases and diabetes, growing geriatric population, and growing preference for point of care testing in these regions. For instance, to identify the glucose level in diabetic people, urine analysis has proven to be an important test. According to the World Health Organization (WHO), an estimated 77 million people above age of 18 years in India are suffering from diabetes (Type 2) and nearly 25 million are pre-diabetics (at a higher risk of developing diabetes in near future).

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa